Human Papiloma Virus Vaccine: ENWAF Assures Bayelsa Health Care Board of Support

Human Papiloma Virus Vaccine: ENWAF Assures Bayelsa Health Care Board of Support

Human Papiloma Virus Vaccine: ENWAF Assures Bayelsa Health Care Board of Support

The Eunice Nnachi Women Advocacy Foundation, ENWAF has assured the Bayelsa State Primary Health Care Board, BYSPHCB of effective collaboration to seamlessly launch the Human Papiloma Virus Vaccine, HPVV, in order to prevent HPV infection and associated diseases, in Bayelsa state.

Founder and CEO of ENWAF, Lady Eunice Nnachi gave the assurance at the expanded meeting on the Introduction of the Human Papiloma Virus (HPV) Introduction and Preventive Measles Vaccination Campaign, supported by SYDANI, at the Bayelsa Health Insurance Scheme BHIS Secretariat in Yenagoa.

She pledged unwavering support to the Board, promising that her foundation will carry out awareness and sensitization campaigns, aimed at informing the public, particularly parents on the need for their girl child aged 9 to14 to receive the HPV vaccine upon its rollout.

On his part, the Executive Secretary Bayelsa State Primary Health Care Board, Dr Appah Williams represented by the State Health Educator, SHE, Mr Ogbointuwei Christopher said the purpose of the Expanded HPVV/ Measles Technical Review meeting was to disclose the preparedness of Bayelsa State as it approaches the eagerly awaited launch of HPV Vaccination on September 25, 2023.

Mr Christopher reeled out the roles, responsibilities and commitment of the members of the Expanded Technical Review Meeting as he commended the team for the outstanding progress thus far.

He also provided the members with strategic guidance to ensure that awareness about the vaccine reaches all eligible individuals and that readiness across board in anticipation of forthcoming launch is achieved.

The HPVV campaigns is scheduled to take place from 25th of September to 29th of September for the (HPVVI) and 5th October 2023 for (Measles), respectively.

Extensive research overwhelmingly confirms the HPV vaccine’s safety, whose primary purpose is to prevent HPV infection and associated diseases, with no impact on fertility.

Human Papiloma Virus, HPV, causes cervical cancer, which is a significant health challenge, and the HPV vaccine is a key solution.

By vaccinating girls aged 9-14 years, Nigeria is paving the way for a future with fewer cases of cervical cancer.

read more:

Back to top button